Equity Fundraising
Artemis Medicare Approves Postal Ballot Process for Fund Raise of Up to ₹700 Crore
NSE
ARTEMISMED
BSE
542919
Artemis Medicare Services Limited has approved the initiation of shareholder approval through postal ballot for raising funds of up to ₹700 crore. The proposed fundraising may be undertaken through issuance of equity shares and/or other eligible securities, subject to shareholder, regulatory, and statutory approvals.
PRICE-SENSITIVE TRIGGER
Event: Board approval to seek shareholder approval for raising funds through issuance of securities.
Type: Equity Fundraising
Impact: Positive
Immediate Effect: The company has formally initiated the shareholder approval process, providing financial flexibility to support future growth initiatives, expansion plans, strategic investments, or balance sheet strengthening.

Key Metrics:
- Proposed Fund Raise: Up to ₹700 crore
- Mode: Equity Shares and/or Other Eligible Securities
- Approval Route: Postal Ballot
- Board Meeting Start Time: 4:30 PM
- Board Meeting End Time: 6:00 PM
Highlight:
- Artemis Medicare plans to raise up to ₹700 crore through issuance of equity shares and/or other eligible securities, subject to shareholder approval.
What Happened ?
Artemis Medicare Services Limited informed stock exchanges that its Board of Directors has approved seeking shareholder approval through a postal ballot for raising funds up to ₹700 crore.
The proposed capital raise may be undertaken through the issuance of equity shares and/or other eligible securities in accordance with applicable provisions of the Companies Act, SEBI ICDR Regulations, and other relevant laws.
The Board has also approved the draft Postal Ballot Notice, which will be circulated to shareholders in due course for obtaining approval.
Key Details
Proposed Capital Raising Exercise:
- Board approved initiation of shareholder approval process through postal ballot.
- Fundraising amount capped at ₹700 crore.
- Capital may be raised through equity shares and/or other eligible securities.
- Issuance structure will be determined by the Board or its authorized committee.
- Fund raise remains subject to shareholder approval.
- Regulatory and statutory approvals will be required before execution.
- Proposed issuance will comply with Companies Act provisions and SEBI ICDR Regulations.
- Board retains flexibility regarding timing, structure, pricing, and investor participation.
- Draft Postal Ballot Notice has been approved by the Board.
- Postal Ballot Notice will be circulated to shareholders in accordance with applicable regulations.
Note:
- The fundraising proposal provides Artemis Medicare with additional capital allocation flexibility and creates a framework for pursuing future growth opportunities while maintaining compliance with regulatory requirements.
Risk Analysis
Summary:
- The proposal is currently at the approval stage. The ultimate impact will depend on shareholder approval, final issuance structure, utilization of proceeds, and market conditions at the time of fundraising.
Key Risks:
- Fundraising remains subject to shareholder approval.
- Regulatory approvals may be required before execution.
- Equity issuance could result in dilution for existing shareholders.
- Final terms, pricing, and instrument structure have not yet been disclosed.
- Market conditions may influence timing and investor participation.
- Deployment efficiency of raised capital will determine long-term value creation.
Worst Case Scenario:
- If shareholder approval is not obtained or market conditions become unfavorable, the proposed fundraising may be delayed, modified, or not proceed as planned.
Risk Level: Medium
Company Commentary
- The Board has approved seeking shareholder approval through postal ballot.
- Fundraising may be undertaken through equity shares and/or other eligible securities.
- The issuance will be carried out in accordance with applicable legal and regulatory provisions.
- The Board or its committee will determine the final structure and terms of the issuance.
- Necessary regulatory and statutory approvals will be obtained before implementation.
- Postal Ballot Notice will be issued to shareholders in due course.
Official Exchange Filing: Artemis Medicare Services Limited